A Double-Blind Randomized Parallel Group Study of Alfuzosin 10mg OD Versus Placebo in the Management of Acute Urinary Retention in Patients With a First Episode Due to Benign Prostatic Hyperplasia (BPH)
Phase of Trial: Phase III
Latest Information Update: 10 Mar 2009
At a glance
- Drugs Alfuzosin (Primary)
- Indications Urinary retention
- Focus Therapeutic Use
- Acronyms ALFAURUS
- Sponsors Sanofi
- 10 Mar 2009 Actual patient number (800) added as reported by ClinicalTrials.gov.
- 25 Sep 2006 New trial record.